Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/12287
Title: ASPECCT: panitumumab versus cetuximab for colorectal cancer.
Authors: Hawkes, Eliza A;Wong, Rachel
Affiliation: Department of Medical Oncology, Eastern Health, Box Hill, VIC, Australia
Department of Oncology, Level 4, Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, PO Box 5555, Heidelberg, VIC 3084, Australia
Issue Date: 1-Jul-2014
Citation: The Lancet. Oncology; 15(8): e302-3
Internal ID Number: 24988927
URI: http://ahro.austin.org.au/austinjspui/handle/1/12287
DOI: 10.1016/S1470-2045(14)70269-4
URL: http://www.ncbi.nlm.nih.gov/pubmed/24988927
Type: Journal Article
Subjects: Antibodies, Monoclonal.therapeutic use
Antibodies, Monoclonal, Humanized.therapeutic use
Antineoplastic Agents.therapeutic use
Colorectal Neoplasms.drug therapy
Female
Humans
Male
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.